News
Press Releases
Pr
Press Release
Seqens confirms the acquisition of CELLforCURE
SEQENS confirms the acquisition of the CELLforCURE site at Les Ulis (91) from NOVARTIS as of December 1st, 2023.
Events and more
01
September 23-26 / Boston, MA
//Meet us booth #70//The 10th CAR-TCR Summit is as the world’s leading global forum to accelerate end-to-end development of cell therapies to patients in need
02
October 6-8 / Phoenix, AZ
//Exhibit table : McArthur ballroom//The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures.
03
November 11-12 / London, UK
//Meet us booth #44//
Follow our presentation, November 12 at 11.15 AM
Track 2: Strategies for Cell Therapy Manufacturing
04
November 18-19 / Philadelphia , PA
//Meet us booth #818 //
The event is designed for the leaders of pioneering ATMP companies and their most senior executives in charge of the latest tech and strategies that are driving the industry forward.
